A sulfonimide derivative of bezafibrate as a dual inhibitor of cyclooxygenase-2 and PPARα
BackgroundPPARα and cyclooxygenase (COX)-2 are overexpressed in certain types of cancer. Thus, developing a dual inhibitor that targets both could be more effective as an anticancer agent than single inhibitors. We have previously shown that an analog of the bezafibrate named AA520 is a PPARα antago...
Saved in:
| Main Authors: | Alessandra Ammazzalorso, Stefania Tacconelli, Annalisa Contursi, Ulrika Hofling, Carmen Cerchia, Sara Di Berardino, Alessandra De Michele, Rosa Amoroso, Antonio Lavecchia, Paola Patrignani |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2024-11-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2024.1488722/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
PPARα exacerbates Salmonella Typhimurium infection by modulating the immunometabolism and macrophage polarization
by: Jessica R. Taddeo, et al.
Published: (2024-12-01) -
Comparative Evaluation of Cyclooxygenase Inhibition Profiles Across Various NSAID Forms and Doses: Implications for Efficacy and Adverse Effects
by: Kenshu Shirakawa, et al.
Published: (2024-12-01) -
Long-chain polyunsaturated fatty acid-containing phosphatidylcholines predict survival rate in patients after heart failure
by: Aleš Kvasnička, et al.
Published: (2024-11-01) -
Exploring COX-Independent Pathways: A Novel Approach for Meloxicam and Other NSAIDs in Cancer and Cardiovascular Disease Treatment
by: Lixia Cheng, et al.
Published: (2024-11-01) -
Platelets as crucial players in the dynamic interplay of inflammation, immunity, and cancer: unveiling new strategies for cancer prevention
by: Annalisa Contursi, et al.
Published: (2024-12-01)